Management of Acute Seizures in Pregnant Women
Immediately administer intravenous lorazepam 4 mg at 2 mg/min as first-line treatment for any pregnant woman actively seizing, followed by levetiracetam or fosphenytoin as second-line therapy if seizures continue. 1
Immediate Critical Actions
Before or simultaneously with medication administration:
- Check fingerstick glucose immediately and correct hypoglycemia—this is a rapidly reversible cause that must not be missed 1
- Have airway equipment at bedside before administering any benzodiazepine, as respiratory depression risk is heightened in pregnancy due to already decreased functional residual capacity 1
- Search for reversible causes including hypoglycemia, hyponatremia, hypoxia, drug toxicity, CNS infection, stroke, intracerebral hemorrhage, and withdrawal syndromes 1
- Do not delay treatment for neuroimaging—CT scanning can be performed after seizure control is achieved 1
First-Line Treatment: Benzodiazepines
Lorazepam is the preferred benzodiazepine with 65% efficacy in terminating status epilepticus and superior performance compared to diazepam (59.1% vs 42.6% seizure termination). 1
Dosing:
- Lorazepam 4 mg IV at 2 mg/min as immediate intervention 1
Alternative benzodiazepine routes if IV access unavailable:
- IM midazolam (effective in prehospital settings) 1
- Intranasal midazolam 1
- Rectal diazepam 0.5 mg/kg up to 20 mg (though absorption may be erratic) 1
Critical pitfall: Benzodiazepines are the drugs of choice for status epilepticus in pregnancy despite theoretical concerns. 2 The risk of uncontrolled seizures far exceeds medication risks. 3, 4
Second-Line Treatment (If Seizures Continue After Adequate Benzodiazepine Dosing)
If the pregnant patient continues seizing after benzodiazepines, immediately escalate to one of these agents:
Preferred Second-Line Options (Listed by Safety Profile in Pregnancy):
1. Levetiracetam (PREFERRED):
- Dose: 30 mg/kg IV (approximately 1000-2000 mg) over 5 minutes 1
- Efficacy: 68-73% in benzodiazepine-refractory status epilepticus 1
- Advantages: Minimal cardiovascular effects, no hypotension risk, favorable safety profile in pregnancy 1, 2
2. Fosphenytoin:
- Dose: 20 mg PE/kg IV at maximum rate of 50 mg/min 1
- Efficacy: 84% 1
- Disadvantages: 12% hypotension risk requiring continuous cardiac monitoring 1
- Suitable second-line agent per guidelines 1, 2
3. Valproate (USE ONLY IF OTHER AGENTS FAIL):
- Dose: 20-30 mg/kg IV over 5-20 minutes 1
- Efficacy: 88% with 0% hypotension risk 1
- Major concern: Significant teratogenic risks, should be avoided in pregnancy when alternatives exist 1, 2
- Should be administered only if other ASMs failed and preferably avoided in first trimester 2
Refractory Status Epilepticus (Seizures Continue Despite Benzodiazepines + One Second-Line Agent)
Definition: Seizures continuing despite benzodiazepines and one second-line agent. 1
At this stage:
- Initiate continuous EEG monitoring 1
- Assemble multidisciplinary team including obstetrics, neurology, and anesthesia 2
Third-Line Anesthetic Agents (in order of preference):
1. Midazolam infusion (FIRST CHOICE):
- Loading dose: 0.15-0.20 mg/kg IV 1
- Continuous infusion: 1 mg/kg/min, titrate up by 1 mg/kg/min every 15 minutes to maximum 5 mg/kg/min 1
- Preferred anesthetic drug for refractory SE in pregnancy 2
2. Propofol (ALTERNATIVE):
- Bolus: 2 mg/kg 1
- Infusion: 3-7 mg/kg/hour 1
- Requires mechanical ventilation but shorter ventilation time than barbiturates 1
- Suitable for refractory SE in pregnancy 2
3. Pentobarbital (MOST EFFECTIVE BUT HIGHEST RISK):
Special Consideration: Eclampsia
If eclampsia is suspected or confirmed:
- Magnesium sulfate is the first-line treatment specifically for eclamptic seizures 2
- However, for ongoing status epilepticus in eclampsia that fails magnesium, follow the same algorithm above with benzodiazepines and second-line agents 3
Last Resort: Termination of Pregnancy
If general anesthetics fail to control refractory status epilepticus, termination of pregnancy via delivery or abortion is recommended. 2 This represents the ultimate intervention when maternal life is at immediate risk.
Critical Pitfalls to Avoid
- Never use neuromuscular blockers alone (such as rocuronium)—they only mask motor manifestations while allowing continued electrical seizure activity and brain injury 1
- Do not skip to third-line agents until benzodiazepines and a second-line agent have been tried 1
- Do not delay anticonvulsant administration for neuroimaging in active status epilepticus 1
- Avoid valproate when alternatives exist due to major teratogenic risks, though it may be necessary if other agents fail 1, 2
- The risk of uncontrolled seizures to both mother and fetus far exceeds the teratogenic risk of anticonvulsants—aggressive treatment is paramount 3, 4, 5
Ongoing Management During Labor
For pregnant patients with known epilepsy during labor:
- Continue baseline antiepileptic medications throughout labor and delivery without interruption 6
- Initiate epidural or combined spinal-epidural analgesia early as pain and stress from contractions can trigger breakthrough seizures even at therapeutic drug levels 6
- Avoid opioid agonist/antagonists as these can precipitate withdrawal and lower seizure threshold 6